James E. Hoyes

James E. Hoyes

Chief Executive Officer at
Alitair Pharmaceuticals, Inc.
Health Technology
Commercial Services
Consumer Non-Durables

Profile

James E.
Hoyes
is currently the Chairman & Chief Executive Officer at Alitair Pharmaceuticals, Inc. He is also a Director at the Biotechnology Innovation Organization and a Director at the Massachusetts Biotechnology Council since 2012.
Previously, he worked as a Director at the Pharmaceutical Research & Manufacturers of America, a Principal at Elan Corp.
Plc, and a Principal at Sterling Drug, Inc. From 2013 to 2013, he served as the President & Head-US Operations at EMD Serono, Inc. He also held positions as a Principal at Sanofi-Synthelabo, Inc. and Sanofi-Aventis Ltd. Mr. Hoyes completed his undergraduate degree at The Pennsylvania State University.

James E. Hoyes active positions

CompaniesPositionStart
Director/Board Member 2012-03-26
Director/Board Member -
Chief Executive Officer 2016-12-31

Former positions of James E. Hoyes

CompaniesPositionEnd
President 2013-09-29
Director/Board Member -
Corporate Officer/Principal -
Corporate Officer/Principal -
Sanofi-Synthelabo, Inc.
Corporate Officer/Principal -
See the detail of James E. Hoyes's experience

Training of James E. Hoyes

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

87

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Commercial Services

Consumer Non-Durables

Consumer Services

Health Technology

Health Technology

Commercial Services

Sanofi-Synthelabo, Inc.

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. James E. Hoyes
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!